Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis

Blood

Volumn 93, Issue 2, 1999, Pages 425-439

  Weiss, Manfred ^a   Moldawer, Lyle L ^b   Schneider, E Marion ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; HUMAN; IMMUNOREGULATION; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0033556353     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.2.425     Document Type: Review

References (173)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864, 1992
2. Bone R: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24:1125, 1996
3. Stuehr DJ, Kwon NS, Gross SS, Thiel BA, Levi R, Nathan CF: Synthesis of nitrogen oxides from L-arginine by macrophage cytosol: Requirement for inducible and constitutive components. Biochem Biophys Res Commun 161:420, 1989
4. Sparrow JR, Nathan C, Vodovotz Y: Cytokine regulation of nitric oxide synthase in mouse retinal pigment epithelial cells in culture. Exp Eye Res 59:129, 1994
5. Xie QW, Nathan C: Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-gamma and bacterial lipopolysaccharide. Trans Assoc Am Physicians 106:1, 1993
6. Nussler AK, Billiar TR: Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 54:171, 1993
7. O'Connor M, Salzman AL, Szabó C: Role of peroxinitrite in the protein oxidation and apoptotic DNA fragmentation in vascular smooth muscle cells stimulated with bacterial lipopolysaccharide and interferon-γ. Shock 8:439, 1997
8. Christ EA, Meals E, English BK: Streptococcal pyogenic exotoxins A (SpeA) and C (SpeC) stimulate the production of inducible nitric oxide synthase (iNOS) protein in RAW 264.7 macrophages. Shock 8:450, 1997
9. Szabo C, Thiemermann C: Invited opinion: Role of nitric oxide in hemorrhagic, traumatic, and anaphylactic shock and thermal injury. Shock 2:145, 1994
10. Kilbourn RG, Szabo C, Traber DL: Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: Lessons learned from experimental and clinical studies. Shock 7:235, 1997
11. Doughty LA, Kaplan SS, Carcillo JA: Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Crit Care Med 24:1137, 1996
12. Friedman G, Jankowski S, Marchant A, Goldman M, Kahn RJ, Vincent JL: Blood interleukin 10 levels parallel the severity of septic shock. J Crit Care 12:183, 1997
13. Villarete LH, Remick DG: Nitric oxide regulation of IL-8 expression in human endothelial cells. Biochem Biophys Res Commun 211:671, 1995
14. Villarete LH, Remick DG: Nitric oxide regulation of interleukin-8 gene expression. Shock 7:29, 1997
15. Bogdan C, Vodovotz Y, Paik J, Xie Q, Nathan C: Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J Leukoc Biol 55:227, 1994
16. Vodovotz Y, Bogdan C, Paik J, Xie QW, Nathan C: Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J Exp Med 178:605, 1993
17. Galley HF, Davies MJ, Webster NR: Xanthine oxidase activity and free radical generation in patients with sepsis syndrome. Crit Care Med 24:1649, 1996
18. Greenacre S, Ridger V, Wilsoncroft P, Brain SD: Peroxynitrite: A mediator of increased microvascular permeability? Clin Exp Pharmacol Physiol 24:880, 1997
19. Szabo C: DNA strand breakage and activation of poly-ADP ribosyltransferase: A cytotoxic pathway triggered by peroxynitrite. Free Radic Biol Med 21:855, 1996
20. Hotchkiss RS, Swanson PE, Cobb JP, Jacobson A, Buchman TG, Karl IE: Apoptosis in lymphoid and parenchymal cells during sepsis: Findings in normal and T-and B-cell-deficient mice. Crit Care Med 25:1298, 1997
21. Jacob AK, Hotchkiss RS, DeMeester SL, Hiramatsu M, Karl IE, Swanson PE, Cobb JP, Buchman TG: Endothelial cell apoptosis is accelerated by inorganic iron and heat via an oxygen radical dependent mechanism. Surgery 122:243, 1997
22. Motoyama S, Minamiya Y, Saito S, Saito R, Matsuzaki I, Abo S, Inaba H, Enomoto K, Kitamura M: Hydrogen peroxide derived from hepatocytes induces sinusoidal endothelial cell apoptosis in perfused hypoxic rat liver. Gastroenterology 114:153, 1998
23. Ayala A, Herdon CD, Lehman DL, Avala CA, Chaudry IH: Differential induction of apoptosis in lymphoid tissues during sepsis: Variation in onset, frequency, and the nature of the mediators. Blood 15:4261, 1996
24. Ayala A, Karr SM, Evans TA, Chaudry IH: Factors responsible for peritoneal granulocyte apoptosis during sepsis. J Surg Res 69:67, 1997
25. Rogy MA, Oldenburg HS, Coyle S, Trousdale R, Moldawer LL, Lowry SF: Correlation between Acute Physiology and Chronic Health Evaluation (APACHE) III score and immunological parameters in critically ill patients with sepsis. Br J Surg 83:396, 1996
26. Lynch DH, Ramsdell F, Alderson MR: Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16:569, 1995
27. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S. Expression of the Fas ligand in cells of T cell lineage. J Immunol 154:3806, 1995
28. Fischer E, Van Zee KJ, Marano MA, Rock CS, Kenney JS, Poutsiaka DD, Dinarello CA, Lowry SF, Moldawer LL: Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 79:2196, 1992
29. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G: Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041, 1993
30. Svenson M, Hansen MB, Heegaard P, Abell K, Bendtzen K: Specific binding of interleukin 1 (IL-1) beta and IL-1 receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I. Cytokine 5:427, 1993
31. Pruitt JH, Copeland EMr, Moldawer LL: Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock. Shock 3:235, 1995
32. Pruitt JH, Welborn MB, Edwards PD, Harward TR, Seeger JW, Martin TD, Smith C, Kenney JA, Wesdorp RI, Meijer S, Cuesta MA, Abouhanze A, Copeland EMr, Giri J, Sims JE, Moldawer LL, Oldenburg HS: Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 87:3282, 1996
33. Opal SM, Fisher CJ Jr, Dhainaut JF, Vincent JL, Brase R, Lowry SF, Sadoff JC, Slotman GJ, Levy H, Balk RA, Shelly MP, Pribble JP, LaBrecque JF, Lookabaugh J, Donovan H, Dubin H, Baughman R, Norman J, DeMaria E, Matzel K, Abraham E, Seneff M: Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med 25:1115, 1997
34. Brandtzaeg P, Osnes L, Ovstebo R, Joo GB, Westvik AB, Kierulf P: Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: Identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med 184:51, 1996
35. Randow F: Mechanism of endotoxin desensitization: Involvement of interleukin 10 and transforming growth factor beta. J Exp Med 181:1887, 1995
36. Marie C, Muret J, Fitting C, Losser MR, Payen D, Cavaillon JM: Reduced ex vivo interleukin-8 production by neutrophils in septic and nonseptic systemic inflammatory response syndrome. Blood 91:3439, 1998
37. Nunes I, Munger JS, Harpel JG, Nagano Y, Shapiro RL, Gleizes PE, Rifkin DB: Structure and activation of the large latent transforming growth factor-beta complex. Int J Obes Relat Metab Disord 20:S4, 1996 (suppl 3)
38. Koeffler HP, Gasson J, Tobler A: Transcriptional and posttranscriptional modulation of myeloid colony-stimulating factor expression by tumor necrosis factor and other agents. Mol Cell Biol 8:3432, 1988
39. Demetri GD, Zenzie BW, Rheinwald JG, Griffin JD: Expression of colony-stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cells lines in vitro. Blood 74:940, 1989
40. Demetri GD, Ernst TJ, Pratt ES 2d, Zenzie BW, Rheinwald JG, Griffin JD: Expression of ras oncogenes in cultured human cells alters the transcriptional and posttranscriptional regulation of cytokine genes. J Clin Invest 86:1261, 1990
41. DellaPuca R, Gallicchio VS: The regulation of phospholipase-A2 (PLA-2) by cytokines expressing hematopoietic growth-stimulating properties. Proc Soc Exp Biol Med 212:174, 1996
42. Nathan CF: Respiratory burst in adherent human neutrophils: Triggering by colony-stimulating factors CSF-GM and CSF-G. Blood 73:301, 1989
43. Vincent JL, Chamlou R: Sepsis trials. Curr Opin Anaesthesiol 9:146, 1996
44. Zeni F, Freeman B, Natanson C: Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment. Crit Care Med 25:1095, 1997
45. Lieschke GJ, Burgess AW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:28, 1992
46. Wang JM, Chen ZG, Colella S, Bonilla MA, Welte K, Bordignon C, Mantovani A: Chemolactic activity of recombinant human granulocyte colony-stimulating factor. Blood 72:1456, 1988
47. Roilides E, Walsh TJ, Pizzo PA, Rubin M: Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 163:579, 1991
48. Repp R, Valerius T, Sendler A, Gramatzki M, Iro H, Kalden JR, Platzer E: Neutrophils express the high affinity receptor for IgG (FcγR1, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor. Blood 78:885, 1991
49. König B, König W: Effect of growth factors on Escherichia coli alpha-hemolysin-induced mediator release from human inflammatory cells: Involvement of the signal transduction pathway. Infect Immun 62:2085, 1994
50. Eichacker PQ, Natanson C: Rethinking the anti-inflammatory approach to septic shock, in Vincent JL (ed): Yearbook of Intensive Care and Emergency Medicine 1996. Berlin, Germany, Springer-Verlag, 1996, p 165
51. Weiss M, Gross-Weege W, Schneider M, Neidhardt H, Liebert S, Mirow N, Wernet P: Enhancement of neutrophil function by in vivo filgrastim treatment for prophylaxis of sepsis in surgical intensive care patients. J Crit Care 10:21, 1995
52. Liu F, Poursine-Laurent J, Wu HY, Link DC: Interleukin-6 and the granulocyte colony-stimulating factor receptor are major independent regulators of granulopoiesis in vivo but are not required for lineage commitment or terminal differentiation. Blood 90:2583, 1997
53. Marsh JC: Long-term bone marrow cultures in aplastic anaemia. Eur J Haematol Suppl 60:75, 1996
54. Philpott NJ, Prue RL, Marsh JC, Gordon Smith EC, Gibson FM: G-CSF-mobilized CD34 peripheral blood stem cells are significantly less apoptotic than unstimulated peripheral blood CD34 cells: role of G-CSF as survival factor. Br J Haematol 97:146, 1997
55. Pitrak DL, Tsai HC, Mullane KM, Sutton SH, Stevens P: Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome. J Clin Invest 98:2714, 1996
56. Matute-Bello G, Liles WC, Radella F2nd, Steinberg KP, Ruzinski JT, Jonas M, Chi EY, Hudson LD, Martin TR: Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med 156:1969, 1997
57. Shimoda K, Okamura S, Harada N, Niho Y: Detection of the granulocyte colony-stimulating factor receptor using biotinylated granulocyte colony-stimulating factor: Presence of granulocyte colony-stimulating factor receptor on CD34-positive hematopoietic progenitor cells. Res Exp Med Berl 192:245, 1992
58. Pan L, Delmonte J Jr, Jalonen CK, Ferrara JL: Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 86:4422, 1995
59. Hartung T, Docke WD, Gantner F, Krieger G, Sauer A, Stevens P, Volk HD, Wendel A: Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85:2482, 1995
60. Dinarello CA, Wolff SM: The role of interleukin-1 in disease. N Engl J Med 328:106, 1993
61. Weiss M, Gross-Weege W, Harms B, Schneider EM: Filgrastim (rhG-CSF) related modulation of the inflammatory response in patients at risk of sepsis or with sepsis. Cytokine 8:260, 1996
62. Pajkrt D, Manten A, van der Poll T, Tiel van Buul MM, Jansen J, Wouter ten Cate J, van Deventer SJ: Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood 90:1415, 1997
63. Weiss M, Gross-Weege W, Moldawer LL, Schneider EM: Relationship of IL-6 and IL-6R to sepsis and septic shock in postoperative/posttraumatic patients. Shock Suppl 7:98, 1997 (abstr)
64. Harms B, Dumon K, Gross-Weege W, Lorenz I, Röher HD, Scharf RE, Schneider EM: Effect of G-CSF-treatment for the prophylaxis of sepsis on the reconstitution of CD14, on neutrophil pre-sensitization and on non-impaired phagocytic function in patients with extended surgery, trauma and hemorrhagic shock. Shock Suppl 7:79, 1997 (abstr)
65. Tian SS, Lamb P, Seidel HM, Stein RB, Rosen J: Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood 84:1760, 1994
66. Zhong Z, Wen Z, Darnell JE Jr: Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6, Science 264:95, 1994
67. Akira S, Nishio Y, Inoue M, Wang XJ, Wei S, Matsusaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T: Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp 130-mediated signaling pathway. Cell 77:63, 1994
68. Tilg H, Dinarello CA, Mier JW: IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators. Immunol Today 18: 428, 1997
69. Nagata S, Fukunaga R: Granulocyte colony-stimulating factor and its receptor. Prog Growth Factor Res 3:131, 1991
70. Omori F, Okamura S, Shimoda K, Otsuka T, Harada M, Niho Y: Levels of human serum granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor under pathological conditions. Biotherapy 4:147, 1992
71. Dunn SM, Coles LS, Lang RK, Gerondakis S, Vadas MA, Shannon MF: Requirement for nuclear factor (NF)-kappa B p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter. Blood 83:2469, 1994
72. Smith LT, Hohaus S, Gonzalez DA, Dziennis SE, Tenen DG: PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood 88:1234, 1996
73. Watari K, Asano S, Shirafuji N, Kodo H, Ozawa K, Takaku F, Karaachi S: Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 73:117, 1989
74. Kawakami M, Tsutsumi H, Kumakawa T, Abe H, Hirai M, Kurosawa S, Mon M, Fukushima M: Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 76:1962, 1990
75. De Haas M, Kerst JM, van der Schoot CE, Calafat J, Hack CE, Nuijens JH, Roos D, van Oers RH, von dem Borne AE: Granulocyte colony-stimulating factor administration to healthy volunteers: Analysis of the immediate activating effects on circulating neutrophils. Blood 84:3885, 1994
76. Aoygai S, Arasawa K, Matsuyuki A, Kamatchi S, Fukushima M, Ohsawa N: Chemiluminescence sandwich enzyme immunoassay for determination of human granulocyte colony stimulating factor (G-CSF). J Biolumin Chemilumin 10:345, 1995
77. Selig C, Nothdurft W: Cytokines and progenitor cells of granulocytopoiesis in peripheral blood of patients with bacterial infections. Infect Immun 63:104, 1995
78. Chen YM, Whang-Peng J, Chern CH, Kuo BIT, Wang SY, Perng RP: The prognostic value of serum cytokine levels in patients with acute infections. Chin Med J (Taipei) 56:75, 1995
79. Tanaka H, Ishikawa K, Nishino M, Shimazu T, Yoshioka T: Changes in granulocyte colony-stimulating factor concentration in patients with trauma and sepsis. J Trauma 40:718, 1996
80. Kragsbjerg P, Holmberg H, Vikerfors T: Dynamics of blood cytokine concentrations in patients with bacteremic infections. Scand J Infect Dis 28:391, 1996
81. Groopman JE: Status of colony-stimulating factors in cancer and AIDS. Semin Oncol 17:31, 1990
82. Welte K, Grabilove J, Bronchud MH, Platzer E, Morstyn G: Filgrastim (r-metHuG-CSF): The first 10 years. Blood 88:1907, 1996
83. Groopman JE: Antiretroviral therapy and immunomodulators in patients with AIDS. Am J Med 90:18s, 1991
84. Sprikkelman A, de Wolf JTM, Vellenga E: The application of hematopoietic growth factors in drug-induced agranulocytosis: A review of 70 cases. Leukemia 8:2031, 1994
85. Kasahara Y, Iwai K, Yachie A, Ohta K, Konno A, Seki H, Miyawaki T, Taniguchi N: Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood 89:1748, 1997
86. Martin MA, Pfaller MA, Wenzel RP: Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Ann Intern Med 110:9, 1989
87. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707, 1996
88. McMahon MM, Bistrian BR: Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 9:1, 1995
89. Smitherman KO, Peacock JE Jr: Infectious emergencies in patients with diabetes mellitus. Med Clin North Am 79:53, 1995
90. Eddleston JM, Sharer NM: Antioxidant therapy in critical illness, in Vincent JL (ed): Yearbook of Intensive Care and Emergency Medicine 1996. Berlin, Germany, Springer-Verlag, 1996, p 96
91. Grimsley EW: Granulocyte colony stimulating factor in the treatment of alcohol abuse, leukopenia, and pneumococcal sepsis. South Med J 88:220, 1995
92. Green DR, Faist E: Trauma and the immune response. Immunol Today 9:253, 1988
93. Dorman T, Breslow MJ: Altered immune function after trauma and hemorrhage: What does it all mean? Crit Care Med 22:1069, 1994
94. Schmand JF, Ayala A, Chaudry IH: Effects of trauma, duration of hypotension, and resuscitation regimen on cellular immunity after hemorrhagic shock. Crit Care Med 22:1076, 1994
95. Brunson ME, Alexander JW: Mechanisms of tranfusion-induced immunosuppression. Transfusion 30:651, 1990
96. Weiss M, Mirow M, Birkhahn A, Schneider M, Wernet P: Benzodiazepines and their solvents influence neutrophil granulocyte function. Br J Anaesth 70:317, 1993
97. Weiss M, Buhl R, Mirow N, Birkhahn A, Schneider M, Wernet P: Do barbiturates impair zymosan-induced granulocyte function? J Crit Care 9:83, 1994
98. Weiss M, Schneider EM, Tarnow J, Mettler S, Krone M, Teschemacher A, Lemoine H: Is inhibition of oxygen radical production of neutrophils by sympathomimetics mediated via β2-adrenoceptors? J Pharmacol Exp Ther 278:1105, 1996
99. Lanser ME, Mao P, Brown G, Coleman B, Siegel J: Serum-mediated depression of neutrophil chemiluminescence following blunt trauma. Ann Surg 202:111, 1985
100. Seekamp A, Regel G, Dwenger A: Interaction of soft tissue trauma and unspecific immune system in polytraumatized patients. Circ Shock 34:34, 1991
101. Solomkin JS, Bauman MP, Nelson RD, Simmons RL: Neutrophils dysfunction during the course of intra-abdominal infection. Ann Surg 194:9, 1981
102. Vespasiano MC, Lewandoski JR, Zimmerman JJ: Longitudinal analysis of neutrophil superoxide anion generation in patients with septic shock. Crit Care Med 21:666, 1993
103. Simms HH, D'Amico R: Polymorphonuclear leukocyte dysregulation during the systemic inflammatory response syndrome. Blood 83:1398, 1994
104. Kropec A, Lemmen SW, Grundmann HJ, Engels I, Daschner FD: Synergy of simultaneous administration of ofloxacin and granulocyte colony-stimulating factor in killing of Escherichia coli by human neutrophils. Infection 23:298, 1995
105. Lundblad R, Nesland JM, Giercksky KE: Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Crit Care Med 24:820, 1996
106. Smith WS, Sumnicht GE, Sharpe RW, Samuelson D, Millard FE: Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of gram-negative pneumonia sepsis: Analysis of survival and multisystem organ failure. Blood 86:1301, 1995
107. O'Reilly M, Silver GM, Greenhalgh DG, Gamelli RL, Davis JH, Hebert JC: Treatment of intra-abdominal infection with granulocyte colony-stimulating factor. J Trauma 33:679, 1992
108. Görgen I, Hartung T, Leist M, Niehörster M, Tiegs G, Uhlig S, Weitzel F, Wendel A: Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-α. J Immunol 149:919, 1992
109. Endo S, Inada K, Inoue Y, Yamada Y, Takakuwa T, Kasai T, Nakae H, Kuwata Y, Hoshi S: Evaluation of recombinant human granulocyte colony-stimulating factor (rhG-CSF) therapy in granulopoetic patients complicated with sepsis. Curr Med Res Opin 13:233, 1994
110. Tkatch LS, Rubin KA, Ziegler SF, Tweardy DJ: Modulation of human G-CSF receptor mRNA and protein in normal and leukemic myeloid cells by G-CSF and retinoic acid. J Leukoc Biol 57:964, 1995
111. Khwaja A, Carver J, Jones HM, Paterson D, Linch DC: Expression and dynamic modulation of the human granulocyte colony-stimulating factor receptor in immature and differentiated myeloid cells. Br J Haematol 85:254, 1993
112. Tasaka K, Doi M, Nakaya N, Mio M: Reinforcement effect of histamine on the differentiation of murine myeloblasts and promyelocytes: Externalization of granulocyte colony-stimulating factor receptors induced by histamine. Mol Pharmacol 45:837, 1994
113. Nicola NA, Vadas MA, Lopez AF: Down-modulation of receptors for granulocyte colony-stimulating factor on human neutrophils by granulocyte-activating agents. J Cell Physiol 128:501, 1986
114. Heard SO, Fink MP, Gamelli RL, Solomkin JS, Joshi M, Trask AL, Fabian TC, Hudson LD, Gerold KB, Logan ED: Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. The Filgrastim Study Group. Crit Care Med 26:748, 1998
115. Emminger W, Emminger-Schmidmeier W, Peters C, Susani M, Hawliczek R, Höcker P, Gadner H: Capillary leak syndrome during low dose granulocyte-macrophage colony-stimulating factor (rhGM-CSF) treatment of a patient in a continuous febrile state. Blut 61:219, 1990
116. Denzlinger C, Holler E, Reisbach G, Hiller E, Wilmanns W: Granulocyte colony-stimulating factor inhibits the endogenous leukotriene production in tumour patients. Br J Haematol 86:881, 1994
117. Squadrito F, Altavilla D, Squadrito G, Campo GM, Ioculano M, Ammedolia L, Arlotta M, Saitta A, Caputi AP: The effects of recombinant human granulocyte colony-stimulating factor on vascular dysfunction and splanchnic ischemia-reperfusion injury. Br J Pharmacol 120:333, 1997
118. Kroncke KD, Fehsel K, Kolb-Bachofen V: Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. Biol Chem Hoppe Seyler 376:327, 1995
119. Liu HW, Anand A, Bloch K, Christiani D, Kradin R: Expression of inducible nitric oxide synthase by macrophages in rat lung. Am J Respir Crit Care Med 156:223, 1997
120. Basu S, Dunn AR, Marino MW, Savoia H, Hodgson G, Lieschke GJ, Cebon J: Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor-deficient mice. J Immunol 159: 1412, 1997
121. Hill AD, Naama H, Shou J, Calvano SE, Daly JM: Antimicrobial effects of granulocyte-macrophage colony-stimulating factor in protein-energy malnutrition. Arch Surg 130:1273, 1995
122. Feder LS, Laskin DL: Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF, and IL-1 beta following acute endotoxemia. J Leukoc Biol 55:507, 1994
123. Nagata M, Sedgwick JB, Busse WW: Differential effects of granulocyte-macrophage colony-stimulating factor on eosinophil and neutrophil superoxide anion generation. J Immunol 155:4948, 1995
124. Stankova J, Rola-Pleszczynski M, Dubois CM: Granulocyte-macrophage colony-stimulating factor increases 5-lipoxygenase gene transcription and protein expression in human neutrophils. Blood 85:3719, 1995
125. Brock TG, McNish RW, Coffey MJ, Ojo TC, Phare SM, Peters-Golden M: Effects of granulocyte-macrophage colony-stimulating factor on eicosanoid production by mononuclear phagocytes. J Immunol 156:2522, 1996
126. McDonald PP, Pouliot M, Borgeat P, McColl SR: Induction by chemokines of lipid mediator synthesis in granulocyte-macrophage colony-stimulating factor-treated human neutrophils. J Immunol 151: 6399, 1993
127. Bober LA, Grace MJ, Pugliese-Sivo C, Rojas-Triana A, Waters T, Sullivan LM, Narula SK: The effect of GM-CSF and G-CSF on human neutrophil function. Immunopharmacology 29:111, 1995
128. Eissner G, Lindner H, Reisbach G, Klauke I, Holler E: Differential modulation of IL-1-induced endothelial adhesion molecules and transendothelial migration of granulocytes by G-CSF. Br J Haematol 97:726, 1997
129. Yong KL: Granulocyte colony-stimulating factor (G-CSF) increases neutrophil migration across vascular endothelium independent of an effect on adhesion: Comparison with granulocyte-macrophage colony-stimulating factor (GM-CSF). Br J Haematol 94:40, 1996
130. Valerius T, Repp R, de Wit TPM, Berthold S, Platzer E, Kalden JR, Gramatzki M, van de Winkel JGJ: Involvement of the high-affinity receptor for IgG (FcγRI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy. Blood 82:931, 1993
131. Spiekermann K, Emmendoerffer A, Eisner J, Raeder E, Lohmann Matthes ML, Prahst A, Link H, Freund M, Welte K, Roesler J: Altered surface marker expression and function of G-CSF-induced neutrophils from test subjects and patients under chemotherapy. Br J Haematol 87:31, 1994
132. Gericke GH, Ericson SG, Pan L, Mills LE, Guyre PM, Ely P: Mature polymorphonuclear leukocytes express high-affinity recepors for IgG (FcγRI) after stimulation with granulocyte colony-stimulating factor (G-CSF). J Leukoc Biol 57:455, 1995
133. Carulli G, Minnucci S, Azzara A, Angiolini C, Sbrana S, Caracciolo F, Ambrogi F: Granulocyte colony-stimulating factor (G-CSF) administration increases PMN CD32 (FcRII) expression and FcR-relaled functions. Haematologica 80:150, 1995
134. Erbe DV, Collins JE, Shen L, Graziano RF, Fange MW: The effect of cytokines on the expression and function of Fc receptors for IgG on human myeloid cells. Mol Immunol 27:57, 1990
135. Ninomiya H, Muraki Y, Shibuya K, Nagasawa T, Abe T: Induction of FcγR-III (CD16) expression on neutrophils affected by paroxysmal nocturnal haemoglobinuria by administration of granulocyte colony-stimulating factor. Br J Haematol 84:497, 1993
136. Gillan ER, Christensen RD, Suen Y, Ellis R, van de Ven C, Cairo MS: A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: Significant induction of peripheral and bone marrow neutrophilia. Blood 84:1427, 1994
137. Kerst JM, de Haas M, van der Schoot CE, Slaper Cortenbach IC, Kleijer M, von dem Borne AE, van Oers RH: Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: Induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 82:3265, 1993
138. Freeman BD, Quezado Z, Zeni F, Natanson C, Danner RL, Banks S, Quezado M, Fitz Y, Bacher J, Eichacker PQ: rG-CSF reduces endotoxemia and improves survival during E. coli pneumonia. J Appl Physiol 83:1467, 1997
139. Kitabayashi A, Hirokawa M, Hatano Y, Lee M, Kuroki J, Niitsu H, Miura AB: Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-alpha production. Blood 86:2220, 1995
140. Aoki Y, Hiromatsu K, Kobayashi N, Hotta T, Saito H, Igarashi H, Niho Y, Yoshikai Y: Protective effect of granulocyte colony-stimulating factor against T-cell-mediated lethal shock triggered by superantigens. Blood 86:1420, 1995
141. Eichacker PQ, Waisman Y, Natanson C, Farese A, Hoffman WD, Banks SM, MacVittie TJ: The cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. J Appl Physiol 77:2366, 1994
142. Lorenz W, Reimund KP, Weitzel F, Celik I, Kurnatowski M, Schneider C, Mannheim W, Heiske A, Neumann K, Sitter H, Rothmund M: Granulocyte colony-stimulating factor prophylaxis before operation protects against lethal consequences of postoperative peritonitis. Surgery 116:925, 1994
143. Haberstroh J, Breuer H, Lücke I, Massarrat K, Früh R, Mand U, Hagedorn P, Brunnberg L, von Specht BU: Effect of recombinant human granulocyte colony-stimulating factor on hemodynamic and cytokine response in a porcine model of pseudomonas sepsis. Shock 4:216, 1995
144. Toki S, Hiromatsu K, Aoki Y, Makino M, Yoshikai Y: Protective effects of granulocyte colony-stimulating factor on endotoxin shock in mice with retrovirus-induced immunodeficiency syndrome. Cytokine 9:781, 1997
145. Pollmächer T, Korth C, Mullington J, Schreiber W, Sauer J, Vedder H, Galanos C, Holsboer F: Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood 87:900, 1996
146. Springer TA: Adhesion receptors of the immune system. Nature 346:425, 1990
147. Hogg N: Roll, roll, roll your leucocyte gently down the vein. Immunol Today 13:113, 1992
148. Strieter RM, Kunkel SL: Acute lung injury: The role of cytokines in the elicitation of neutrophils. J Invest Med 42:643, 1994
149. Korthuis RJ, Anderson DC, Granger DN: Role of neutrophil-endothelial cell adhesion in inflammatory disorders. J Crit Care 9:47, 1994
150. Tedder TF, Steeber DA, Pizcueta P: L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J Exp Med 181:2259, 1995
151. Ohsaka A, Saionji K, Sato N, Mori T, Ishimoto K, Inamatsu T: Granulocyte colony-stimulating factor down-regulates the surface expression of the human leukocyte adhesion molecule-1 on human neutrophils in vitro and in vivo. Br J Haematol 84:574, 1993
152. Preece G, Murphy G, Ager A: Metalloproteinase-mediated regulation of L-selectin levels on leucocytes. J Biol Chem 271:11634, 1996
153. Cowley HC, Heney D, Gearing AJH, Hemingway I, Webster NR: Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study. Crit Care Med 22:651, 1994
154. Weiss M, Schneider EM, Radermacher P: Low dose G-CSF to augment host defense and counteract progression of sepsis, in Vincent JL (ed): Yearbook of Intensive Care and Emergency Medicine 1996. Berlin, Germany, Springer-Verlag, 1996, p 150
155. Sessler CN, Windsor AC, Schwartz M, Watson L, Fisher BJ, Sugerman HJ, Fowler AA: Circulating ICAM-1 is increased in septic shock. Am J Respir Crit Care Med 151:1420, 1995
156. Xu BH, Gonzalo JA, Pierre YS, Williams IR, Kupper TS, Cotran RS, Springer TA, Gutierrez-Ramos JC: Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J Exp Med 180:95, 1994
157. Schilero GJ, Oropello J, Benjamin E: Impairment in gas exchange after granulocyte colony-stimulating factor (G-CSF) in a patient with the adult respiratory distress syndrome. Chest 107:276, 1995
158. Demuynck H, Zachee P, Verhoef GE, Schetz M, van den Berghe G, Lauwers P, Boogaerts MA: Risks of rhG-CSF treatment in drug-induced agranulocytosis. Ann Hematol 70:143, 1995
159. Nelson S, Summer W, Bagby G, Nakamura C, Stewart L, Lipscomb G, Andresen J: Granulocyte colony-stimulating factor enhances pulmonary host defenses in normal and ethanol-treated rats. J Infect Dis 164:901, 1991
160. Hebert JC, O'Reilly M, Gamelli RL: Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice. Arch Surg 125:1075, 1990
161. Lister PD, Gentry MJ, Preheim LC: Granulocyte colony-stimulating factor protects control rats but not ethanol-fed rats from fatal pneumococcal pneumonia. J Infect Dis 168:922, 1993
162. Abraham E, Stevens P: Effects of granulocyte colony-stimulating factor in modifying mortality from Pseudomonas aeruginosa pneumonia after hemorrhage. Crit Care Med 20:1127, 1992
163. Heyll A, Aul C, Gogolin F, Thomas M, Arning M, Gehrt A, Hadding U: Granulocyte colony-stimulating factor (G-CSF) treatment in a neutropenic leukemia patient with diffuse interstitial pulmonary infiltrates. Ann Hematol 63:328, 1991
164. Dale DC: The use of colony-stimulating factors for the prevention and treatment of infections. Shock Suppl 7:81, 1997 (abstr)
165. Gross-Weege W, Weiss M, Schneider M, Wenning M, Harms B, Dumon K, Ohmann C, Röher HD: Safety of a low-dosage filgrastim (rhG-CSF) treatment in non-neutropenic surgical intensive care patients with an inflammatory process. Intensive Care Med 23:16, 1997
166. Held TK, Mielke ME, Chedid M, Unger M, Trautmann M, Huhn D, Cross AS: Granulocyte colony-stimulating factor worsens the outcome of experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria. Blood 91:2525, 1998
167. Hierholzer C, Kelly E, Tsukada K, Loeffert E, Watkins S, Billiar TR, Tweardy DJ: Hemorrhagic shock induces G-CSF expression in bronchial epithelium. Am J Physiol 273:L1058, 1997
168. Hierholzer C, Kelly E, Lyons V, Roedling E, Davies P, Billiar TR, Tweardy DJ: G-CSF instillation into rat lungs mediates neutrophil recruitment, pulmonary edema, and hypoxia. J Leukoc Biol 63:169, 1998
169. Lundblad R, Wang MY, Kvalheim G, Lingaas E, Giercksky KE: Granulocyte colony-stimulating factor improves myelopoiesis and host defense in fulminant intraabdominal sepsis in rats. Shock 4:68, 1995
170. Welborn MBr, Douglas WG, Abouhamze Z, Auffenburg T, Abouhamze AS, Baumhofer J, Seeger JM, Pruitt JH, Edwards PD, Chizzonite R, Martin D, Moldawer LL, Harward TR: Visceral ischemia-reperfusion injury promotes tumor necrosis factor (TNF) and interleukin-1 (IL-1) dependent organ injury in the mouse. Shock 6:171, 1996
171. Ras GJ, Anderson R, Lecatsas G, Sher R: Acquired neutrophil dysfunction in male homosexuals with the acquired immunodeficiency syndrome. S Afr Med J 65:873, 1984
172. Takahashi T, Wada T, Mon M, Kokai Y, Ishii S: Overexpression of the granulocyte colony-stimulating factor gene leads to osteoporosis in mice. Lab Invest 74:827, 1996
173. Hommes DW, Meenan J, Dijkhuizen S, Ten-Kate FJ, Tytgat GN, van Deventer SJ: Efficacy of recombinant granulocyte colony-stimulating factor (rhG-CSF) in experimental colitis. Clin Exp Immunol 106:529, 1996